Skip to main content
TipRanks
Go Ultimate75% OFF

Ivy Cosmetics Corporation (4918) AI Stock Analysis

0 Followers
JP:4918

Ivy Cosmetics Corporation

(TSE/TYO:4918)

Select Model
Rating:81Outperform
Price Target:JPY 552.00â–²(15.48% Upside)
Action:reiterated
Date:11/14/26

Ivy Cosmetics achieves a strong overall score, driven primarily by an attractive valuation and exceptionally robust upside price momentum. The company benefits from an ironclad balance sheet and excellent cash flow generation, though this is partially tempered by ongoing weakness in top-line revenue growth.

Positive Factors
Profitability RecoveryGross margin near 70% and restored net margins around 6% in 2024 and 2026 indicate the business can retain substantial value from sales while profitability has recovered. If maintained, this provides a durable base for reinvestment and resilience.
Negative Factors
Revenue ContractionRevenue declined about 9.8% in 2026 after stronger 2025 performance, showing that top-line expansion is not consistently established. Persistent uneven growth could limit operating leverage, reduce reinvestment capacity, and make future profitability more dependent on cost control.

Ivy Cosmetics Corporation (4918) vs. iShares MSCI Japan ETF (EWJ)

-30%-20%-10%0%10%20%30%40%50%JP:4918+49.04%EWJ+16.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 3.00B
Dividend Yield
3.14%
Average Volume (3M)
27.02K
Price to Earnings (P/E)
14.3
Beta (1Y)
1.20
Revenue Growth
-5.54%
EPS Growth
-55.93%
Country
Japan
Employees
179
Sector
General
Sector Strength
55
Industry
Household & Personal Products

Ivy Cosmetics Corporation Business Overview & Revenue Model

Company Description

Ivy Cosmetics Corporation manufactures and distributes a comprehensive array of cosmetic products and beauty-enhancing supplements. Their extensive catalog includes fundamental skincare items like deep-penetrating beauty liquids, various lotions, emu...

Ivy Cosmetics Corporation Financial Statement Overview

Summary

The company demonstrates exceptional financial stability with an aggressively deleveraged balance sheet and robust free cash flow generation. However, the score is constrained by a persistent decline in top-line revenue despite improving net profit margins.

Income Statement

55Neutral

Balance Sheet

85Very Positive

Cash Flow

88Very Positive
Financial statement breakdown
BreakdownMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue2.64B2.93B2.71B2.94B3.53B
Gross Profit1.84B2.07B1.91B2.11B2.42B
EBITDA236.31M20.62M242.60M-33.16M185.13M
Net Income164.53M43.01M160.31M-384.61M40.38M
Balance Sheet
Total Assets3.64B3.57B3.57B3.85B4.49B
Cash, Cash Equivalents and Short-Term Investments1.04B577.94M208.73M247.67M129.38M
Total Debt278.01M211.34M451.69M1.05B1.18B
Total Liabilities1.00B1.10B1.33B1.87B2.22B
Stockholders Equity2.64B2.47B2.24B1.98B2.27B
Cash Flow
Free Cash Flow385.37M424.68M408.70M243.33M-160.58M
Operating Cash Flow451.04M445.94M453.06M278.59M-107.06M
Investing Cash Flow-58.15M-18.43M7.30M-29.30M63.30M
Financing Cash Flow70.61M-58.27M-499.31M-131.00M59.71M

Ivy Cosmetics Corporation Technical Analysis

Technical Analysis SentimentPositive
Last Price478.00

Price Trends

50DMA307.52Positive
100DMA309.41Positive
200DMA322.01Positive

Market Momentum

MACD20.27Negative
RSI90.85Negative
STOCH100.00Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4918, the sentiment is Positive. The current price of 478.00 is above the 20-day moving average (MA) of 317.95, above the 50-day MA of 307.52, and above the 200-day MA of 322.01, indicating a bullish trend. The MACD of 20.27 indicates Negative momentum. The RSI at 90.85 is Negative, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4918.

Ivy Cosmetics Corporation Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:4918 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4918JP:491881OutperformJPY 2.26B14.34―3.14%-5.54%-55.93%
JP:4925JP:492580OutperformJPY 6.30B9.22―2.40%-2.92%-25.96%
JP:4926JP:492665NeutralJPY 5.32B20.89―1.61%1.51%-18.54%
JP:4920JP:492058NeutralJPY 2.23B8.24―2.82%9.96%2053.18%
JP:4929JP:492956NeutralJPY 5.92B36.88―1.63%-1.71%314.83%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:4934JP:493450NeutralJPY 4.64B12.74――-14.09%-22.72%

* General Sector Average

Performance Comparison

-20%0%20%40%JP:4918JP:4920JP:4925JP:4926JP:4929JP:4934Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:4918 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4918Ivy Cosmetics Corporation478.00163.9852.22%
JP:4920Nippon Shikizai, Inc.1055.002.570.24%
JP:4925HABA Laboratories, Inc.1660.0033.962.09%
JP:4926C'BON COSMETICS Co., Ltd.1243.0061.405.20%
JP:4929ADJUVANT HOLDINGS CO., LTD.735.00-9.91-1.33%
JP:4934Premier Anti-Aging Co., Ltd.532.00-166.00-23.78%

Ivy Cosmetics Corporation Corporate Events

Ivy Cosmetics Reports September 2026 Sales and Profit Growth

Nov 11, 2026

The release identifies Ivy Cosmetics Corporation as a general-business company listed on Tokyo’s stock exchanges, but does not specify its industry, primary products or services, or market focus.For the September 2026 reporting period, net sales rose...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 14, 2026